Abstract
In the adaptive cell and gene therapy field, T cells are currently receiving a lot of focus and showing success in making it to the market – but natural killer (NK) cells are beginning to close this gap. In particular, CAR NK cells for cancer cell therapy offer a number of distinct advantages. But what benefits, and what challenges, do CAR NK cells pose? In this article and expert discussion the manufacturing, analytics, and functionality of CAR NK cells will be discussed, along with further engineering strategies to overcome some of the obstacles still facing this modality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
